Crosstalk between gut microbiota and sepsis.

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Sepsis is a life-threatening inflammatory condition triggered by infection.
• Current sepsis management strategies present significant clinical challenges.
• Emerging research highlights the gut microbiome's critical role in host homeostasis.

Purpose of the Study:

• To review the intricate relationship between the gastrointestinal ecosystem and sepsis.
• To explore the potential of microbiota-targeted therapies for improving sepsis outcomes.

Main Methods:

• Literature review focusing on the gut microbiome's influence on sepsis.
• Analysis of host-microbiota interactions in the context of critical illness.
• Evaluation of current and novel microbiota-based therapeutic approaches.

Main Results:

• Gut microbiota significantly regulate immune responses, gut barrier integrity, and susceptibility to disease.
• Restoring or maintaining gut microbiota composition shows therapeutic promise.
• Existing microbiota-based treatments like fecal microbiota transplantation and probiotics have limitations in proven efficacy.

Conclusions:

• The gut microbiome is a key factor in sepsis pathogenesis and progression.
• Targeting the gut microbiota represents a promising avenue for novel sepsis therapies.
• Further research is needed to optimize microbiota-based interventions for sepsis treatment.